These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9167946)
21. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Wright PA; Lemoine NR; Goretzki PE; Wyllie FS; Bond J; Hughes C; Röher HD; Williams ED; Wynford-Thomas D Oncogene; 1991 Sep; 6(9):1693-7. PubMed ID: 1923534 [TBL] [Abstract][Full Text] [Related]
22. Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors. Challeton C; Bounacer A; Du Villard JA; Caillou B; De Vathaire F; Monier R; Schlumberger M; Suárez HG Oncogene; 1995 Aug; 11(3):601-3. PubMed ID: 7630645 [TBL] [Abstract][Full Text] [Related]
23. Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens. Giordano TJ; Beaudenon-Huibregtse S; Shinde R; Langfield L; Vinco M; Laosinchai-Wolf W; Labourier E Hum Pathol; 2014 Jul; 45(7):1339-47. PubMed ID: 24830619 [TBL] [Abstract][Full Text] [Related]
24. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632 [TBL] [Abstract][Full Text] [Related]
25. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours. Banito A; Pinto AE; Espadinha C; Marques AR; Leite V Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453 [TBL] [Abstract][Full Text] [Related]
26. p53 mutations in all stages of thyroid carcinomas. Zou M; Shi Y; Farid NR J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453 [TBL] [Abstract][Full Text] [Related]
27. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868 [TBL] [Abstract][Full Text] [Related]
28. [Origin and progression of thyroid epithelial tumors: molecular and cellular mechanisms]. Gire V; Wynford-Thomas D Arch Anat Cytol Pathol; 1998; 46(1-2):11-8. PubMed ID: 9754356 [TBL] [Abstract][Full Text] [Related]
29. [Genetic causes of the thyroid carcinomas]. Jindrichová S; Vlcek P; Bendlová B Cas Lek Cesk; 2004; 143(10):664-8. PubMed ID: 15584614 [TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
31. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359 [TBL] [Abstract][Full Text] [Related]
32. [Unique association of p53 mutations with undifferentiated carcinoma of the thyroid]. Ito T; Seyama T; Hayashi Y; Dohi K; Akiyama M Nihon Rinsho; 1994 Apr; 52(4):1069-74. PubMed ID: 8196165 [TBL] [Abstract][Full Text] [Related]
33. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048 [TBL] [Abstract][Full Text] [Related]
37. [The role of genetic factors in the pathogenesis of thyroid neoplasms]. Ferenc T; Maciaszczyk K; Gesing A; Lewiński A Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100 [TBL] [Abstract][Full Text] [Related]
38. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643 [TBL] [Abstract][Full Text] [Related]
39. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Liu RT; Chen YJ; Chou FF; Li CL; Wu WL; Tsai PC; Huang CC; Cheng JT Clin Endocrinol (Oxf); 2005 Oct; 63(4):461-6. PubMed ID: 16181240 [TBL] [Abstract][Full Text] [Related]